Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 501–600 of 1,018
Clinicopathologic features of frontotemporal dementia with Progranulin sequence variation
Spina, S., Murrell, J. R., Huey, E. D., Wassermann, E. M., Pietrini, P., Baraibar, M. A., Barbeito, A. G., Troncoso, J. C., Vidal, R., Ghetti, B., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254460.31273.2d · Cited by 78
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
Borroni, B., Benussi, A., Archetti, S., Galimberti, D., Parnetti, L., Nacmias, B., Sorbi, S., Scarpini, E., & Padovani, A. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.971812 · Cited by 77
“These include pathogenic mutations in the Microtubule Associated Protein Tau ( MAPT) (2,3,8) gene, underlying Tau pathology, and mutations in the progranulin ( GRN ) (4,5,9,10), Transactive Response DNA-Binding Protein ( TARDBP) (6,11,12) and C9orf72 (13,14) genes associated with TDP pathology.”
BackgroundProgranulin-associated PiB-negative logopenic primary progressive aphasia
Josephs, K. A., Duffy, J. R., Strand, E. A., Machulda, M. M., Vemuri, P., Senjem, M. L., Perkerson, R. B., Baker, M. C., Lowe, V., Jack, C. R., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7243-9 · Cited by 78
Self-citationProgranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH
Butler, V. J., Cortopassi, W. A., Argouarch, A. R., Ivry, S. L., Craik, C. S., Jacobson, M. P., & Kao, A. W. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.027 · Cited by 77
The Ubiquitin System in Alzheimer’s Disease
Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 85
Ke, Y. D., van Hummel, A., Stevens, C. H., Gladbach, A., Ippati, S., Bi, M., Lee, W. S., Krüger, S., van der Hoven, J., Volkerling, A. M., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1486-0 · Cited by 86
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
Whitwell, J. L., Jack, C. R., Parisi, J. E., Senjem, M. L., Knopman, D. S., Boeve, B. F., Rademakers, R., Baker, M., Petersen, R. C., Dickson, D. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e31820203c2 · Cited by 77
Self-citationHeterogeneity within a large kindred with frontotemporal dementia: A novel progranulin mutation
Bruni, A. C., Momeni, P., Bernardi, L., Tomaino, C., Frangipane, F., Elder, J., Kawarai, T., Sato, C., Pradella, S., Wakutani, Y., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000265220.64396.b4 · Cited by 77
Suarez-Calvet, M., Dols-Icardo, O., Llado, A., Sanchez-Valle, R., Hernandez, I., Amer, G., Anton-Aguirre, S., Alcolea, D., Fortea, J., Ferrer, I., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305972 · Cited by 77
Alquézar, C., Salado, I. G., de la Encarnación, A., Pérez, D. I., Moreno, F., Gil, C., de Munaín, A. L., Martínez, A., & Martín‐Requero, Á. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0102-7 · Cited by 87
Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
Van Kampen, J. M., Baranowski, D., & Kay, D. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097032 · Cited by 76
“activated microglia [3,14], PGRN is known to be a critical”
BackgroundCorticobasal Ganglionic Degeneration
Josephs, K. A. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00022-2 · Cited by 77
Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS
Ito, D., & Suzuki, N. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343365 · Cited by 76
Opening up the DNA methylome of dementia
Delgado-Morales, R., & Esteller, M. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.242 · Cited by 76
Progranulin antibodies in autoimmune diseases
Thurner, L., Preuss, K., Fadle, N., Regitz, E., Klemm, P., Zaks, M., Kemele, M., Hasenfus, A., Csernok, E., Gross, W. L., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.10.003 · Cited by 76
Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
Chen, H., Kankel, M. W., Su, S. C., Han, S., & Ofengeim, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0060-4 · Cited by 78
Loss of TMEM 106B potentiates lysosomal and FTLD ‐like pathology in progranulin‐deficient mice
Werner, G., Damme, M., Schludi, M., Gnörich, J., Wind, K., Fellerer, K., Wefers, B., Wurst, W., Edbauer, D., Brendel, M., et al. (2020) · EMBO reports · doi:10.15252/embr.202050241 · Cited by 75
Muynck, L. D., Herdewyn, S., Beel, S., Scheveneels, W., Bosch, L. V. D., Robberecht, W., & Damme, P. V. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.022 · Cited by 75
Nguyen, A. D., Nguyen, T. A., Zhang, J., Devireddy, S., Zhou, P., Karydas, A. M., Xu, X., Miller, B. L., Rigo, F., Ferguson, S. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722344115 · Cited by 74
Progress and Challenges in Frontotemporal Dementia Research: A 20-Year Review
Hodges, J. R., & Piguet, O. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171087 · Cited by 74
Analysis of IFT74as a candidate gene for chromosome 9p-linked ALS-FTD
Momeni, P., Schymick, J., Jain, S., Cookson, M. R., Cairns, N. J., Greggio, E., Greenway, M. J., Berger, S., Pickering-Brown, S., Chiò, A., et al. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-44 · Cited by 74
Self-citationFrontotemporal Dementia with Tau Pathology
Gasparini, L., Terni, B., & Spillantini, M. G. (2007) · Neurodegenerative Diseases · doi:10.1159/000101848 · Cited by 74
Molecular Genetics of Neurodegenerative Dementias
Hinz, F. I., & Geschwind, D. H. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023705 · Cited by 73
Boeve, B. F. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815bf454 · Cited by 73
Self-citationImpaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 81
Younes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.006 · Cited by 72
Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains
Jian, J., Zhao, S., Tian, Q., González-Gugel, E., Mundra, J. J., Uddin, S. M. Z., Liu, B., Richbourgh, B., Brunetti, R., & Liu, C.-J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.09.024 · Cited by 73
Brain progranulin expression in GRN-associated frontotemporal lobar degeneration
Chen-Plotkin, A. S., Xiao, J., Geser, F., Martinez-Lage, M., Grossman, M., Unger, T., Wood, E. M., Van Deerlin, V. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0576-2 · Cited by 73
Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation
Bersano, A., Bo, R. D., Lamperti, C., Ghezzi, S., Fagiolari, G., Fortunato, F., Ballabio, E., Moggio, M. G., Candelise, L., Galimberti, D., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.009 · Cited by 79
Monamì, G., Emiliozzi, V., Bitto, A., Lovat, F., Xu, S., Goldoni, S., Fassan, M., Serrero, G., Gomella, L. G., Baffa, R., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080735 · Cited by 76
S6K2: The Neglected S6 Kinase Family Member
Pardo, O. E., & Seckl, M. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00191 · Cited by 86
Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
Mendsaikhan, A., Tooyama, I., & Walker, D. G. (2019) · Cells · doi:10.3390/cells8030230 · Cited by 72
“Initial papers observed features of PGRN immunoreactivity in microglia around senile plaques in AD cases when comparison was being made with neuropathological features of FTLD due to GRN mutations [13,127].”
ResultImplications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Haukedal, H., & Freude, K. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.004 · Cited by 68
Arrant, A. E., Roth, J. R., Boyle, N. R., Kashyap, S. N., Hoffmann, M. Q., Murchison, C. F., Ramos, E. M., Nana, A. L., Spina, S., Grinberg, L. T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0872-6 · Cited by 73
Sevigny, J., Uspenskaya, O., Heckman, L. D., Wong, L. C., Hatch, D. A., Tewari, A., Vandenberghe, R. R., Irwin, D. J., Saracino, D., Ber, I. L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02973-0 · Cited by 90
Mechanisms of Granulin Deficiency: Lessons from Cellular and Animal Models
Kleinberger, G., Capell, A., Haass, C., & Van Broeckhoven, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8380-8 · Cited by 71
Klein, C., Schneider, S. A., & Lang, A. E. (2009) · Movement Disorders · doi:10.1002/mds.22675 · Cited by 72
Progranulin expression is upregulated after spinal contusion in mice
Naphade, S. B., Kigerl, K. A., Jakeman, L. B., Kostyk, S. K., Popovich, P. G., & Kuret, J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0616-y · Cited by 72
Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis
Curtis, A. F., Masellis, M., Hsiung, G.-Y. R., Moineddin, R., Zhang, K., Au, B., Millett, G., Mackenzie, I., Rogaeva, E., & Tierney, M. C. (2017) · Neurology · doi:10.1212/wnl.0000000000004494 · Cited by 72
Self-citationFrontotemporal Lobar Degeneration: Current Concepts in the Light of Recent Advances
Kumar‐Singh, S., & Van Broeckhoven, C. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00055.x · Cited by 72
Seilhean, D., Cazeneuve, C., Thuriès, V., Russaouen, O., Millecamps, S., Salachas, F., Meininger, V., LeGuern, E., & Duyckaerts, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0545-9 · Cited by 71
TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., & Ke, Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157781 · Cited by 71
“Haploinsufficiency caused by an autosomal dominant mutation within GRN is a major cause of familial FTD [89,93].”
BackgroundRecent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Kirola, L., Mukherjee, A., & Mutsuddi, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02934-z · Cited by 83
Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration
Gendron, T. F., Josephs, K. A., & Petrucelli, L. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01060.x · Cited by 71
Almeida, S., Zhou, L., & Gao, F.-B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026454 · Cited by 71
TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander
Banks, G. T., Kuta, A., Isaacs, A. M., & Fisher, E. M. C. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9117-x · Cited by 71
The Evolution of the Secreted Regulatory Protein Progranulin
Palfree, R. G. E., Bennett, H. P. J., & Bateman, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133749 · Cited by 70
Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology
Whitwell, J. L., & Josephs, K. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.7 · Cited by 83
Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis
Roczniak-Ferguson, A., & Ferguson, S. M. (2019) · Life Science Alliance · doi:10.26508/lsa.201900358 · Cited by 68
Josephs, K. A., Duffy, J. R., Clark, H. M., Utianski, R. L., Strand, E. A., Machulda, M. M., Botha, H., Martin, P. R., Pham, N. T. T., Stierwalt, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23687-8 · Cited by 70
Self-citationLehnert, S., Costa, J., de Carvalho, M., Kirby, J., Kuzma-Kozakiewicz, M., Morelli, C., Robberecht, W., Shaw, P., Silani, V., Steinacker, P., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.884592 · Cited by 69
Sporadic corticobasal syndrome due to FTLD-TDP
Tartaglia, M. C., Sidhu, M., Laluz, V., Racine, C., Rabinovici, G. D., Creighton, K., Karydas, A., Rademakers, R., Huang, E. J., Miller, B. L., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0605-1 · Cited by 69
Self-citationThe Neuronal Workspace Model: Conscious Processing and Learning
Changeux, J., & Dehaene, S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00078-4 · Cited by 80
FTD and ALS—translating mouse studies into clinical trials
Ittner, L. M., Halliday, G. M., Kril, J. J., Götz, J., Hodges, J. R., & Kiernan, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.65 · Cited by 68
Recent Advances in the Genetics of Frontotemporal Dementia
Sirkis, D. W., Geier, E. G., Bonham, L. W., Karch, C. M., & Yokoyama, J. S. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0160-6 · Cited by 68
Fenoglio, C., Galimberti, D., Cortini, F., Kauwe, J. S. K., Cruchaga, C., Venturelli, E., Villa, C., Serpente, M., Scalabrini, D., Mayo, K., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1170 · Cited by 68
Kleinberger, G., Wils, H., Ponsaerts, P., Joris, G., Timmermans, J., Van Broeckhoven, C., & Kumar‐Singh, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06961.x · Cited by 68
Ferrari, R., Grassi, M., Salvi, E., Borroni, B., Palluzzi, F., Pepe, D., D'Avila, F., Padovani, A., Archetti, S., Rainero, I., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.005 · Cited by 67
Frontotemporal dementia and primary progressive aphasia, a review
Kirshner, H. S. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s38821 · Cited by 84
Busch, J. I., Unger, T. L., Jain, N., Skrinak, R. T., Charan, R. A., & Chen-Plotkin, A. S. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw127 · Cited by 68
Lowe, J. S., Mirra, S. S., Hyman, B. T., & Dickson, D. W. (2008) · CRC Press eBooks · doi:10.1201/b13319-15 · Cited by 72
Self-citation(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64076-5.00027-2 · Cited by 67
Rousseaux, M. W. C., Vázquez-Vélez, G. E., Al-Ramahi, I., Jeong, H.-H., Bajić, A., Revelli, J.-P., Ye, H., Phan, E. T., Deger, J. M., Perez, A. M., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0254-18.2018 · Cited by 61
“Specifically, we used one-way ANOVA followed by correction for false discovery rate of 10% via the two-stage step-up method of Benjamini and Yekutieli (2006).”
MethodZhou, X., Nicholson, A. M., Ren, Y., Brooks, M., Jiang, P., Zuberi, A., Phuoc, H. N., Perkerson, R. B., Matchett, B., Parsons, T. M., et al. (2020) · Brain · doi:10.1093/brain/awaa141 · Cited by 66
Self-citationProgranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease
Sheng, J., Su, L., Xu, Z., & Chen, G. (2014) · Gene · doi:10.1016/j.gene.2014.03.041 · Cited by 65
The Neuropathology of FTD Associated With ALS
Mackenzie, I. R. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c3486 · Cited by 78
Self-citationNew approaches to the treatment of frontotemporal lobar degeneration
Vossel, K. A., & Miller, B. L. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328318444d · Cited by 67
NG2/CSPG4 and progranulin in the posttraumatic glial scar
Schäfer, M. K. E., & Tegeder, I. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.10.002 · Cited by 73
Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues
Ferrari, R., Manzoni, C., & Hardy, J. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.006 · Cited by 67
Roberson, E. D., & Kao, A. W. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.010 · Cited by 67
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1
Wider, C. W., Melquist, S., Hauf, M., Solida, A., Cobb, S. A., Kachergus, J. M., Gass, J., Coon, K. D., Baker, M., Cannon, A. D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000275527.35752.c5 · Cited by 66
Self-citationAlzheimer Disease–like Phenotype Associated With the c.154delA Mutation in Progranulin
Kelley, B. J., Haidar, W., Boeve, B. F., Baker, M., Shiung, M., Knopman, D. S., Rademakers, R., Hutton, M., Adamson, J., Kuntz, K. M., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.113 · Cited by 66
Self-citationAccumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging
Perneel, J., Neumann, M., Heeman, B., Cheung, S., den Broeck, M. V., Wynants, S., Baker, M. C., Vicente, C. T., Faura, J., Rademakers, R., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02531-3 · Cited by 76
Self-citationMutations in Progranulin Gene: Clinical, Pathological, and Ribonucleic Acid Expression Findings
de Munaín, A. L., Alzualde, A., Gorostidi, A., Otaegui, D., Ruiz‐Martínez, J., Indakoetxea, B., Ferrer, I., Pérez‐Tur, J., Sáenz, A., Bergareche, A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.015 · Cited by 74
Nuclear bodies in neurodegenerative disease
Woulfe, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.005 · Cited by 74
Van Broeck, B., Van Broeckhoven, C., & Kumar-Singh, S. (2007) · Neurodegenerative Diseases · doi:10.1159/000105156 · Cited by 65
Thalamic atrophy in frontotemporal dementia — Not just a C9orf72 problem
Bocchetta, M., Gordon, E., Cardoso, M. J., Modat, M., Ourselin, S., Warren, J. D., & Rohrer, J. D. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.02.019 · Cited by 65
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Baldacci, F., Mazzucchi, S., Vecchia, A. D., Giampietri, L., Giannini, N., Koronyo‐Hamaoui, M., Ceravolo, R., Siciliano, G., Bonuccelli, U., Elahi, F. M., et al. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1731306 · Cited by 68
How the immune system shapes neurodegenerative diseases
Mason, H. D., & McGavern, D. B. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.08.001 · Cited by 69
He, Y., Kaya, I., Shariatgorji, M., Lundkvist, J., Wahlberg, L. U., Nilsson, A., Mamula, D., Kehr, J., Zarȩba-Pasławska, J., Biverstål, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41539-5 · Cited by 66
Cerami, C., Marcone, A., Galimberti, D., Villa, C., Scarpini, E., & Cappa, S. F. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110788 · Cited by 64
RNA‐binding proteins in neurodegenerative disease: TDP‐43 and beyond
Hanson, K. A., Kim, S. H., & Tibbetts, R. S. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.111 · Cited by 75
Rovelet‐Lecrux, A., Deramecourt, V., Legallic, S., Maurage, C., Ber, I. L., Brice, A., Lambert, J., Frébourg, T., Hannequin, D., Pasquier, F., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.004 · Cited by 73
Galimberti, D., Bonsi, R., Fenoglio, C., Serpente, M., Cioffi, S., Fumagalli, G., Arighi, A., Ghezzi, L., Arcaro, M., Mercurio, M., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.05.006 · Cited by 69
Premi, E., Cauda, F., Gasparotti, R., Diano, M., Archetti, S., Padovani, A., & Borroni, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106500 · Cited by 63
Hwang, H., Jung, T. W., Hong, H. C., Choi, H. Y., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Choi, D. S., Baik, S. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076679 · Cited by 249
Premi, E., Grassi, M., van Swieten, J., Galimberti, D., Graff, C., Masellis, M., Tartaglia, C., Tagliavini, F., Rowe, J. B., Laforce Jr, R., et al. (2017) · Brain · doi:10.1093/brain/awx103 · Cited by 63
Self-citationGoldman, J. S., & Van Deerlin, V. M. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0347-7 · Cited by 63
Nosology of Primary Progressive Aphasia and the Neuropathology of Language
Mesulam, M. M., Coventry, C., Bigio, E. H., Geula, C., Thompson, C. K., Bonakdarpour, B., Gefen, T. D., Rogalski, E. J., & Weıntraub, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_3 · Cited by 72
Nag, S., & Schneider, J. A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00846-7 · Cited by 76
Lipids as Emerging Biomarkers in Neurodegenerative Diseases
Wei, J. C., Wong, L. C., & Boland, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010131 · Cited by 65
Guo, A., Tapia, L., Bamji, S. X., Cynader, M. S., & Jia, W. W.-G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.099 · Cited by 64
Barmada, S. J., & Finkbeiner, S. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.4.251 · Cited by 61
Involvement of Granulin in Estrogen-Induced Neurogenesis in the Adult Rat Hippocampus
CHIBA, S., SUZUKI, M., YAMANOUCHI, K., & NISHIHARA, M. (2007) · Journal of Reproduction and Development · doi:10.1262/jrd.18108 · Cited by 62
The role of CHMP2B in frontotemporal dementia
Urwin, H., Ghazi-Noori, S., Collinge, J., & Isaacs, A. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370208 · Cited by 62
Hatanpaa, K. J., Bigio, E. H., Cairns, N. J., Womack, K. B., Weintraub, S., Morris, J. C., Foong, C., Xiao, G., Hladik, C., Mantanona, T. Y., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a12a6 · Cited by 62
Genomic editing opens new avenues for zebrafish as a model for neurodegeneration
Schmid, B., & Haass, C. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12460 · Cited by 74
Toh, H., Cao, M., Daniels, E., & Bateman, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064989 · Cited by 62
Parkinsonism and Frontotemporal Dementia: The Clinical Overlap
Espay, A. J., & Litvan, I. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9632-1 · Cited by 62
“Inherited FTLD-TDP comprises FTDP associated with progranulin (PGRN) gene mutations (FTDP-17U/PGRN; Baker et al. 2006), as well as Perry syndrome associated with dynactin 1 mutations (Farrer et al.”
BackgroundChitramuthu, B. P., Baranowski, D. C., Kay, D. G., Bateman, A., & Bennett, H. P. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-41 · Cited by 62
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.